Skip to main content
Top
Published in: Current Gastroenterology Reports 5/2012

01-10-2012 | Small Intestine (J Sellin, Section Editor)

Clinical Implications of Enteroadherent Escherichia coli

Authors: Margarita M. P. Arenas-Hernández, Ygnacio Martínez-Laguna, Alfredo G. Torres

Published in: Current Gastroenterology Reports | Issue 5/2012

Login to get access

Abstract

Pathogenic Escherichia coli that colonize the small intestine primarily cause gastrointestinal illness in infants and travelers. The main categories of pathogenic E. coli that colonize the epithelial lining of the small intestine are enterotoxigenic E. coli, enteropathogenic E. coli, and enteroaggregative E. coli. These organisms accomplish their pathogenic process by a complex, coordinated multistage strategy, including nonintimate adherence mediated by various adhesins. These so called “enteroadherent E. coli” categories subsequently produce toxins or effector proteins that are either secreted to the milieu or injected to the host cell. Finally, destruction of the intestinal microvilli results from the intimate adherence or the toxic effect exerted over the epithelia, resulting in water secretion and diarrhea. In this review, we summarize the current state of knowledge regarding these enteroadherent E. coli strains and the present clinical understanding of how these organisms colonize the human intestine and cause disease.
Literature
1.
go back to reference Torres AG, Zhou X, Kaper JB. Adherence of diarrheagenic Escherichia coli strains to epithelial cells. Infect Immun. 2005;73:18–29.PubMedCrossRef Torres AG, Zhou X, Kaper JB. Adherence of diarrheagenic Escherichia coli strains to epithelial cells. Infect Immun. 2005;73:18–29.PubMedCrossRef
2.
3.
go back to reference WHO. Future Directions for Research on Enterotoxigenic Escherichia coli Vaccines for Developing Countries. Wkly Epidemiol Rec. 2006;81:97–104. WHO. Future Directions for Research on Enterotoxigenic Escherichia coli Vaccines for Developing Countries. Wkly Epidemiol Rec. 2006;81:97–104.
4.
go back to reference Wang M, Szucs TD, Steffen R. Economic aspects of travelers’ diarrhea. J Travel Med. 2008;15:110–8.PubMedCrossRef Wang M, Szucs TD, Steffen R. Economic aspects of travelers’ diarrhea. J Travel Med. 2008;15:110–8.PubMedCrossRef
5.
go back to reference Qadri F, Saha A, Ahmed T, Al Tarique A, Begum YA, Svennerholm AM. Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh. Infect Immun. 2007;75:3961–8.PubMedCrossRef Qadri F, Saha A, Ahmed T, Al Tarique A, Begum YA, Svennerholm AM. Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh. Infect Immun. 2007;75:3961–8.PubMedCrossRef
6.
go back to reference Fleckenstein JM, Hardwidge PR, Munson GP, Rasko DA, Sommerfelt H, Steinsland H. Molecular mechanisms of enterotoxigenic Escherichia coli infection. Microbes Infect. 2010;12:89–98.PubMedCrossRef Fleckenstein JM, Hardwidge PR, Munson GP, Rasko DA, Sommerfelt H, Steinsland H. Molecular mechanisms of enterotoxigenic Escherichia coli infection. Microbes Infect. 2010;12:89–98.PubMedCrossRef
7.
go back to reference Qadri F, Svennerholm AM, Faruque AS, Sack RB. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev. 2005;18:465–83.PubMedCrossRef Qadri F, Svennerholm AM, Faruque AS, Sack RB. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev. 2005;18:465–83.PubMedCrossRef
8.
go back to reference Svennerholm AM, Tobias J. Vaccines against enterotoxigenic Escherichia coli. Expert Rev Vaccines. 2008;7:795–804.PubMedCrossRef Svennerholm AM, Tobias J. Vaccines against enterotoxigenic Escherichia coli. Expert Rev Vaccines. 2008;7:795–804.PubMedCrossRef
9.
go back to reference Gaastra W, Svennerholm AM. Colonization factors of human enterotoxigenic Escherichia coli (ETEC). Trends Microbiol. 1996;4:444–52.PubMedCrossRef Gaastra W, Svennerholm AM. Colonization factors of human enterotoxigenic Escherichia coli (ETEC). Trends Microbiol. 1996;4:444–52.PubMedCrossRef
10.
go back to reference Turner SM, Scott-Tucker A, Cooper LM, Henderson IR. Weapons of mass destruction: virulence factors of the global killer enterotoxigenic Escherichia coli. FEMS Microbiol Lett. 2006;263:10–20.PubMedCrossRef Turner SM, Scott-Tucker A, Cooper LM, Henderson IR. Weapons of mass destruction: virulence factors of the global killer enterotoxigenic Escherichia coli. FEMS Microbiol Lett. 2006;263:10–20.PubMedCrossRef
11.
go back to reference Dorsey FC, Fischer JF, Fleckenstein JM. Directed delivery of heat-labile enterotoxin by enterotoxigenic Escherichia coli. Cell Microbiol. 2006;8:1516–27.PubMedCrossRef Dorsey FC, Fischer JF, Fleckenstein JM. Directed delivery of heat-labile enterotoxin by enterotoxigenic Escherichia coli. Cell Microbiol. 2006;8:1516–27.PubMedCrossRef
12.
go back to reference Johnson AM, Kaushik RS, Francis DH, Fleckenstein JM, Hardwidge PR. Heat-labile enterotoxin promotes Escherichia coli adherence to intestinal epithelial cells. J Bacteriol. 2009;191:178–86.PubMedCrossRef Johnson AM, Kaushik RS, Francis DH, Fleckenstein JM, Hardwidge PR. Heat-labile enterotoxin promotes Escherichia coli adherence to intestinal epithelial cells. J Bacteriol. 2009;191:178–86.PubMedCrossRef
13.
go back to reference Lasaro MA, Mathias-Santos C, Rodrigues JF, Ferreira LC. Functional and immunological characterization of a natural polymorphic variant of a heat-labile toxin (LT-I) produced by enterotoxigenic Escherichia coli (ETEC). FEMS Immunol Med Microbiol. 2009;55:93–9.PubMedCrossRef Lasaro MA, Mathias-Santos C, Rodrigues JF, Ferreira LC. Functional and immunological characterization of a natural polymorphic variant of a heat-labile toxin (LT-I) produced by enterotoxigenic Escherichia coli (ETEC). FEMS Immunol Med Microbiol. 2009;55:93–9.PubMedCrossRef
14.
go back to reference Yoder JS, Cesario S, Plotkin V, Ma X, Kelly-Shannon K, Dworkin MS. Outbreak of enterotoxigenic Escherichia coli infection with an unusually long duration of illness. Clin Infect Dis. 2006;42:1513–7.PubMedCrossRef Yoder JS, Cesario S, Plotkin V, Ma X, Kelly-Shannon K, Dworkin MS. Outbreak of enterotoxigenic Escherichia coli infection with an unusually long duration of illness. Clin Infect Dis. 2006;42:1513–7.PubMedCrossRef
15.
go back to reference Hill DR. Occurrence and self-treatment of diarrhea in a large cohort of Americans traveling to developing countries. AmJTrop Med Hyg. 2000;62:585–9. Hill DR. Occurrence and self-treatment of diarrhea in a large cohort of Americans traveling to developing countries. AmJTrop Med Hyg. 2000;62:585–9.
16.
go back to reference Steffen R, Castelli F, Dieter Nothdurft H, Rombo L, Jane Zuckerman N. Vaccination against enterotoxigenic Escherichia coli, a cause of travellers’ diarrhea. J Travel Med. 2005;12:102–7.PubMedCrossRef Steffen R, Castelli F, Dieter Nothdurft H, Rombo L, Jane Zuckerman N. Vaccination against enterotoxigenic Escherichia coli, a cause of travellers’ diarrhea. J Travel Med. 2005;12:102–7.PubMedCrossRef
17.
go back to reference Sack DA, Shimko J, Torres O, Bourgeois AL, Francia DS, Gustafsson B, et al. Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. coli diarrhea of travellers to Guatemala and Mexico. Vaccine. 2007;25:4392–400.PubMedCrossRef Sack DA, Shimko J, Torres O, Bourgeois AL, Francia DS, Gustafsson B, et al. Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. coli diarrhea of travellers to Guatemala and Mexico. Vaccine. 2007;25:4392–400.PubMedCrossRef
18.
go back to reference DuPont HL, Haynes GA, Pickering LK, Tjoa W, Sullivan P, Olarte J. Diarrhea of travelers to Mexico. Relative susceptibility of United States and Latin American students attending a Mexican University. Am J Epidemiol. 1977;105:37–41.PubMed DuPont HL, Haynes GA, Pickering LK, Tjoa W, Sullivan P, Olarte J. Diarrhea of travelers to Mexico. Relative susceptibility of United States and Latin American students attending a Mexican University. Am J Epidemiol. 1977;105:37–41.PubMed
19.
go back to reference Svennerholm AM. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development. Indian J Med Res. 2011;133:188–94.PubMed Svennerholm AM. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development. Indian J Med Res. 2011;133:188–94.PubMed
20.
go back to reference • Harro C, Sack D, Bourgeois AL, Walker R, DeNearing B, Feller A, et al. Combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults. Clin Vaccine Immunol. 2011;18:2118–27. This report describes the safety and immunogenicity results from the first-in-human dose-escalation trial of ACE527, a three live attenuated ETEC vaccine strains that collectively express several CSs and LTB. PubMedCrossRef • Harro C, Sack D, Bourgeois AL, Walker R, DeNearing B, Feller A, et al. Combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults. Clin Vaccine Immunol. 2011;18:2118–27. This report describes the safety and immunogenicity results from the first-in-human dose-escalation trial of ACE527, a three live attenuated ETEC vaccine strains that collectively express several CSs and LTB. PubMedCrossRef
21.
go back to reference • Crossman LC, Chaudhuri RR, Beatson SA, Wells TJ, Desvaux M, Cunningham AF, et al. A commensal gone bad: complete genome sequence of the prototypical enterotoxigenic Escherichia coli strain H10407. J Bacteriol. 2010;192:822–31. This paper describes for the first time the complete genomic sequence of E. coli H10407, a prototypical strain of enterotoxigenic E. coli. CrossRef • Crossman LC, Chaudhuri RR, Beatson SA, Wells TJ, Desvaux M, Cunningham AF, et al. A commensal gone bad: complete genome sequence of the prototypical enterotoxigenic Escherichia coli strain H10407. J Bacteriol. 2010;192:822–31. This paper describes for the first time the complete genomic sequence of E. coli H10407, a prototypical strain of enterotoxigenic E. coli. CrossRef
22.
go back to reference Harris JA, Roy K, Woo-Rasberry V, Hamilton DJ, Kansal R, Qadri F, et al. Directed evaluation of enterotoxigenic Escherichia coli autotransporter proteins as putative vaccine candidates. PLoS Negl Trop Dis. 2011;5:e1428.PubMedCrossRef Harris JA, Roy K, Woo-Rasberry V, Hamilton DJ, Kansal R, Qadri F, et al. Directed evaluation of enterotoxigenic Escherichia coli autotransporter proteins as putative vaccine candidates. PLoS Negl Trop Dis. 2011;5:e1428.PubMedCrossRef
23.
go back to reference Wagner A, Wiedermann U. Travellers’ diarrhoea—pros and cons of different prophylactic measures. Wien Klin Wochenschr. 2009;121:13–8.PubMedCrossRef Wagner A, Wiedermann U. Travellers’ diarrhoea—pros and cons of different prophylactic measures. Wien Klin Wochenschr. 2009;121:13–8.PubMedCrossRef
24.
go back to reference Frech SA, Dupont HL, Bourgeois AL, McKenzie R, Belkind-Gerson J, Figueroa JF, et al. Use of a patch containing heat-labile toxin from Escherichia coli against travellers’ diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet. 2008;371:2019–25.PubMedCrossRef Frech SA, Dupont HL, Bourgeois AL, McKenzie R, Belkind-Gerson J, Figueroa JF, et al. Use of a patch containing heat-labile toxin from Escherichia coli against travellers’ diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet. 2008;371:2019–25.PubMedCrossRef
25.
go back to reference Flores J, Okhuysen PC. Enterotoxigenic Escherichia coli. In: Torres AG, editor. Pathogenic Escherichia coli in Latin America. Bentham Sciencie Publishers Ltd.; 2010. pp. 84–94. Flores J, Okhuysen PC. Enterotoxigenic Escherichia coli. In: Torres AG, editor. Pathogenic Escherichia coli in Latin America. Bentham Sciencie Publishers Ltd.; 2010. pp. 84–94.
26.
go back to reference • Koo HL, DuPont HL. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol. 2010;26:17–25. This review describes the most recent advances in rifaximin treatment and prevention of travelers’ diarrhea. PubMedCrossRef • Koo HL, DuPont HL. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol. 2010;26:17–25. This review describes the most recent advances in rifaximin treatment and prevention of travelers’ diarrhea. PubMedCrossRef
27.
go back to reference Koo HL, DuPont HL, Huang DB. The role of rifaximin in the treatment and chemoprophylaxis of travelers’ diarrhea. Ther Clin Risk Manag. 2009;5:841–8.PubMed Koo HL, DuPont HL, Huang DB. The role of rifaximin in the treatment and chemoprophylaxis of travelers’ diarrhea. Ther Clin Risk Manag. 2009;5:841–8.PubMed
28.
go back to reference Lapointe TK, O’Connor PM, Buret AG. The role of epithelial malfunction in the pathogenesis of enteropathogenic E. coli-induced diarrea. Lab Invest. 2009;89:964–70.PubMedCrossRef Lapointe TK, O’Connor PM, Buret AG. The role of epithelial malfunction in the pathogenesis of enteropathogenic E. coli-induced diarrea. Lab Invest. 2009;89:964–70.PubMedCrossRef
29.
go back to reference Wong AR, Pearson JS, Bright MD, Munera D, Robinson KS, Lee SF, et al. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol Microbiol. 2011;80:1420–38.PubMedCrossRef Wong AR, Pearson JS, Bright MD, Munera D, Robinson KS, Lee SF, et al. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol Microbiol. 2011;80:1420–38.PubMedCrossRef
30.
go back to reference Bardiau M, Szalo M, Mainil JG. Initial adherence of EPEC, EHEC and VTEC to host cells. Vet Res. 2010;41:57.PubMedCrossRef Bardiau M, Szalo M, Mainil JG. Initial adherence of EPEC, EHEC and VTEC to host cells. Vet Res. 2010;41:57.PubMedCrossRef
31.
go back to reference Humphries RM, Armstrong GD. Sticky situation: localized adherence of enteropathogenic Escherichia coli to the small intestine epithelium. Future Microbiol. 2010;5:1645–61.PubMedCrossRef Humphries RM, Armstrong GD. Sticky situation: localized adherence of enteropathogenic Escherichia coli to the small intestine epithelium. Future Microbiol. 2010;5:1645–61.PubMedCrossRef
32.
go back to reference Gomes TAT, Gonzalez-Pedrajo B. Enteropathogenic Escherichia coli (EPEC). In: Torres AG, editor. Pathogenic Escherichia coli in Latin America.: Betham Science Publishers Ltd; 2010. pp. 25–47. Gomes TAT, Gonzalez-Pedrajo B. Enteropathogenic Escherichia coli (EPEC). In: Torres AG, editor. Pathogenic Escherichia coli in Latin America.: Betham Science Publishers Ltd; 2010. pp. 25–47.
33.
go back to reference Hernandes RT, Elias WP, Vieira MAM, Gomes TAT. An overview of atypical enteropathogenic Escherichia coli. FEMS Microbiol Lett. 2009;297:137–49.PubMedCrossRef Hernandes RT, Elias WP, Vieira MAM, Gomes TAT. An overview of atypical enteropathogenic Escherichia coli. FEMS Microbiol Lett. 2009;297:137–49.PubMedCrossRef
34.
go back to reference Scaletsky ICA, Souza TB, Aranda KRS, Okeke IN. Genetic elements associated with antimicrobial resistance in enteropathogenic Escherichia coli (EPEC) from Brazil. BMC Microbiol. 2010;10:25.PubMedCrossRef Scaletsky ICA, Souza TB, Aranda KRS, Okeke IN. Genetic elements associated with antimicrobial resistance in enteropathogenic Escherichia coli (EPEC) from Brazil. BMC Microbiol. 2010;10:25.PubMedCrossRef
35.
go back to reference • Ochoa TJ, Contreras CA. Enteropathogenic Escherichia coli infection in children. Curr Opin Infect Dis. 2011;24:478–83. This review discussed the current knowledge about atypical EPEC as a human pathogen. PubMedCrossRef • Ochoa TJ, Contreras CA. Enteropathogenic Escherichia coli infection in children. Curr Opin Infect Dis. 2011;24:478–83. This review discussed the current knowledge about atypical EPEC as a human pathogen. PubMedCrossRef
36.
go back to reference Bugarel M, Martin A, Fach P, Beutin L. Virulence gene profiling of enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli strains: a basis for molecular risk assessment of typical and atypical EPEC strains. BMC Microbiol. 2011;11:142.PubMedCrossRef Bugarel M, Martin A, Fach P, Beutin L. Virulence gene profiling of enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli strains: a basis for molecular risk assessment of typical and atypical EPEC strains. BMC Microbiol. 2011;11:142.PubMedCrossRef
37.
go back to reference Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol. 2010;8:26–38.PubMed Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol. 2010;8:26–38.PubMed
38.
go back to reference • Calderon Toledo C, Arvidsson I, Karpman D. Cross-reactive protection against enterohemorrhagic Escherichia coli infection by enteropathogenic E. coli in a mouse model. Infect Immun. 2011;79:2224–33. Using a murine model of infection, this study shows that enteropathogenic E. coli infections may protect against enterohemorrhagic E. coli infections. PubMedCrossRef • Calderon Toledo C, Arvidsson I, Karpman D. Cross-reactive protection against enterohemorrhagic Escherichia coli infection by enteropathogenic E. coli in a mouse model. Infect Immun. 2011;79:2224–33. Using a murine model of infection, this study shows that enteropathogenic E. coli infections may protect against enterohemorrhagic E. coli infections. PubMedCrossRef
39.
go back to reference Pawlowski SW, Warren CA, Guerrant R. Diagnosis and treatment of acute or persistent diarrhea. Gastroenterology. 2009;136:1874–86.PubMedCrossRef Pawlowski SW, Warren CA, Guerrant R. Diagnosis and treatment of acute or persistent diarrhea. Gastroenterology. 2009;136:1874–86.PubMedCrossRef
40.
go back to reference Hodges K, Gill R. Infectious diarrea. Cellular and molecular mechanisms. Gut Microb. 2010;1:4–21.CrossRef Hodges K, Gill R. Infectious diarrea. Cellular and molecular mechanisms. Gut Microb. 2010;1:4–21.CrossRef
41.
go back to reference Abba K, Sinfield R, Hart CA, Garner P. Pathogens associated with persistent diarrhea in children in low and middle income countries: systematic review. BMC Infect Dis. 2009;9:88.PubMedCrossRef Abba K, Sinfield R, Hart CA, Garner P. Pathogens associated with persistent diarrhea in children in low and middle income countries: systematic review. BMC Infect Dis. 2009;9:88.PubMedCrossRef
42.
go back to reference García PG, Silva VL, Dinis CG. Ocurrence and antimicrobial Drug Susceptibility Patterns of commensal and diarrheagenic Escherichia coli in fecal microbiota from children with and without acute diarrhea. J Microbiol. 2011;49:46–52.PubMedCrossRef García PG, Silva VL, Dinis CG. Ocurrence and antimicrobial Drug Susceptibility Patterns of commensal and diarrheagenic Escherichia coli in fecal microbiota from children with and without acute diarrhea. J Microbiol. 2011;49:46–52.PubMedCrossRef
43.
go back to reference Ochoa TJ, Barletta F, Contreras C, Mercado E. New insights into the epidemiology of enteropathogenic Escherichia coli infection. Trans R Soc Trop Med Hyg. 2008;102:852–6.PubMedCrossRef Ochoa TJ, Barletta F, Contreras C, Mercado E. New insights into the epidemiology of enteropathogenic Escherichia coli infection. Trans R Soc Trop Med Hyg. 2008;102:852–6.PubMedCrossRef
44.
go back to reference Fagundes-Neto U, Scaletsky IC. The gut at war: the consequences of enteropathogenic Escherichia coli infection as a factor of diarrhea and malnutrition. Sao Paulo Med J. 2000;118:21–9.PubMedCrossRef Fagundes-Neto U, Scaletsky IC. The gut at war: the consequences of enteropathogenic Escherichia coli infection as a factor of diarrhea and malnutrition. Sao Paulo Med J. 2000;118:21–9.PubMedCrossRef
45.
go back to reference Liu ZH, Shen TY, Zhang P, Ma YL, Moyer MP, Qin HL. Protective effects of Lactobacillus plantarum against epithelial barrier dysfunction of human colon cell line NCM460. World J Gastroenterol. 2010;16:5759–65.PubMedCrossRef Liu ZH, Shen TY, Zhang P, Ma YL, Moyer MP, Qin HL. Protective effects of Lactobacillus plantarum against epithelial barrier dysfunction of human colon cell line NCM460. World J Gastroenterol. 2010;16:5759–65.PubMedCrossRef
46.
go back to reference Britton RA, Versalovic J. Probiotics and gastrointestinal infections. Interdiscip Perspect Infect Dis. 2008;2008:290769.PubMed Britton RA, Versalovic J. Probiotics and gastrointestinal infections. Interdiscip Perspect Infect Dis. 2008;2008:290769.PubMed
47.
go back to reference Hardegen C, Messler S, Henrich B, Pfeffer K, Würthner J, MacKenzie CR. A set of novel multiplex Taqman real-time PCRs for the detection of diarrhoeagenic Escherichia coli and its use in determining the prevalence of EPEC and EAEC in a university hospital. Ann Clin Microbiol Antimicrob. 2010;9:5.PubMedCrossRef Hardegen C, Messler S, Henrich B, Pfeffer K, Würthner J, MacKenzie CR. A set of novel multiplex Taqman real-time PCRs for the detection of diarrhoeagenic Escherichia coli and its use in determining the prevalence of EPEC and EAEC in a university hospital. Ann Clin Microbiol Antimicrob. 2010;9:5.PubMedCrossRef
48.
go back to reference Mainil JG, Bardiau M, Ooka T, Ogura Y, Murase K, Etoh Y, et al. Typing of O26 enterohaemorrhagic and enteropathogenic Escherichia coli isolated from humans and cattle with IS621 multiplex PCR-based fingerprinting. J Appl Microbiol. 2011;111:773–86.PubMedCrossRef Mainil JG, Bardiau M, Ooka T, Ogura Y, Murase K, Etoh Y, et al. Typing of O26 enterohaemorrhagic and enteropathogenic Escherichia coli isolated from humans and cattle with IS621 multiplex PCR-based fingerprinting. J Appl Microbiol. 2011;111:773–86.PubMedCrossRef
49.
go back to reference Bouzari S, Aslani MM, Oloomi M, Jafari A, Dashti A. Comparison of multiplex PCR with serogrouping and PCR-RFLP of fliC gene for the detection of enteropathogenic Escherichia coli (EPEC). Braz J Infect Dis. 2011;15:365–9.PubMed Bouzari S, Aslani MM, Oloomi M, Jafari A, Dashti A. Comparison of multiplex PCR with serogrouping and PCR-RFLP of fliC gene for the detection of enteropathogenic Escherichia coli (EPEC). Braz J Infect Dis. 2011;15:365–9.PubMed
50.
go back to reference • Botkin DJ, Galli L, Sankarapani V, Soler M, Rivas M, Torres AG. Development of a Multiplex PCR Assay for detection of Shiga toxin-producing Escherichia coli, enterohemorrhagic E. coli, and enteropathogenic E. coli strains. Front Microbiol. 2012;2:1. This new mPCR methodology permitted the differentiation of enteropathogenic E. coli, Shiga toxin-producing E. coli, and enterohemorrhagic E. coli strains from other pathogenic E. coli. • Botkin DJ, Galli L, Sankarapani V, Soler M, Rivas M, Torres AG. Development of a Multiplex PCR Assay for detection of Shiga toxin-producing Escherichia coli, enterohemorrhagic E. coli, and enteropathogenic E. coli strains. Front Microbiol. 2012;2:1. This new mPCR methodology permitted the differentiation of enteropathogenic E. coli, Shiga toxin-producing E. coli, and enterohemorrhagic E. coli strains from other pathogenic E. coli.
51.
go back to reference Flores J, Okhuysen PC. Enteroaggregative Escherichia coli infection. Curr Opin Gastroenterol. 2009;25:8–11.PubMedCrossRef Flores J, Okhuysen PC. Enteroaggregative Escherichia coli infection. Curr Opin Gastroenterol. 2009;25:8–11.PubMedCrossRef
52.
go back to reference Harrington SM, Dudley EG, Nataro JP. Pathogenesis of enteroaggregative Escherichia coli infection. FEMS Microbiol Lett. 2006;254:12–8.PubMedCrossRef Harrington SM, Dudley EG, Nataro JP. Pathogenesis of enteroaggregative Escherichia coli infection. FEMS Microbiol Lett. 2006;254:12–8.PubMedCrossRef
53.
go back to reference Weintraub A. Enteroaggregative Escherichia coli: epidemiology, virulence and detection. J Med Microbiol. 2007;56:4–8.PubMedCrossRef Weintraub A. Enteroaggregative Escherichia coli: epidemiology, virulence and detection. J Med Microbiol. 2007;56:4–8.PubMedCrossRef
54.
go back to reference Andrade JA, Freymüller E, Fagundes-Neto U. Adherence of enteroaggregative Escherichia coli to the ileal and colonic mucosa: an in vitro study utilizing the scanning electron microscopy. Arq Gastroenterol. 2011;48:199–204.PubMedCrossRef Andrade JA, Freymüller E, Fagundes-Neto U. Adherence of enteroaggregative Escherichia coli to the ileal and colonic mucosa: an in vitro study utilizing the scanning electron microscopy. Arq Gastroenterol. 2011;48:199–204.PubMedCrossRef
55.
go back to reference Dudley EG, Abe C, Ghigo JM, Latour-Lambert P, Hormazabul JC, Nataro JP. An IncI1 plasmid contributes to the adherence of the atypical enteroaggregative Escherichia coli strain C1096 to cultured cells and abiotic surfaces. Infect Immun. 2006;74:2102–14.PubMedCrossRef Dudley EG, Abe C, Ghigo JM, Latour-Lambert P, Hormazabul JC, Nataro JP. An IncI1 plasmid contributes to the adherence of the atypical enteroaggregative Escherichia coli strain C1096 to cultured cells and abiotic surfaces. Infect Immun. 2006;74:2102–14.PubMedCrossRef
56.
go back to reference Abe CM, Knutton S, Pedroso MZ, Freymüller E, Gomes TA. An enteroaggregative Escherichia coli strain of serotype O111:H12 damages and invades cultured T84 cells and human colonic mucosa. FEMS Microbiol Lett. 2001;203:199–205.PubMedCrossRef Abe CM, Knutton S, Pedroso MZ, Freymüller E, Gomes TA. An enteroaggregative Escherichia coli strain of serotype O111:H12 damages and invades cultured T84 cells and human colonic mucosa. FEMS Microbiol Lett. 2001;203:199–205.PubMedCrossRef
57.
go back to reference Pereira AC, Britto-Filho JD, de Carvalho JJ, das Gracas de Luna M, Rosa AC. Enteroaggregative Escherichia coli (EAEC) strains enter and survive within cultured epithelial cells. Microb Pathog. 2008;45:310–4.PubMedCrossRef Pereira AC, Britto-Filho JD, de Carvalho JJ, das Gracas de Luna M, Rosa AC. Enteroaggregative Escherichia coli (EAEC) strains enter and survive within cultured epithelial cells. Microb Pathog. 2008;45:310–4.PubMedCrossRef
58.
go back to reference Sobieszczańska B, Duda AK, Turniak M, Duda-Madej A, Franiczek R, Kasprzykowska U. Characterization of genes associated with internalization of enteroaggregative Escherichia coli. Microb Pathog. 2011;50:141–7.PubMedCrossRef Sobieszczańska B, Duda AK, Turniak M, Duda-Madej A, Franiczek R, Kasprzykowska U. Characterization of genes associated with internalization of enteroaggregative Escherichia coli. Microb Pathog. 2011;50:141–7.PubMedCrossRef
59.
go back to reference Konno T, Yatsuyanagi J, Saito S. Virulence gene profiling of enteroaggregative Escherichia coli heat-stable enterotoxin 1-harboring E. coli (EAST1EC) derived from sporadic diarrheal patients. FEMS Immunol Med Microbiol. 2011;[Epub ahead of print]. Konno T, Yatsuyanagi J, Saito S. Virulence gene profiling of enteroaggregative Escherichia coli heat-stable enterotoxin 1-harboring E. coli (EAST1EC) derived from sporadic diarrheal patients. FEMS Immunol Med Microbiol. 2011;[Epub ahead of print].
60.
go back to reference Navarro-Garcia F. Enteroaggregative Escherichia coli plasmid-encoded toxin. Future Microbiol. 2010;5:1005–13.PubMedCrossRef Navarro-Garcia F. Enteroaggregative Escherichia coli plasmid-encoded toxin. Future Microbiol. 2010;5:1005–13.PubMedCrossRef
61.
go back to reference Cappello RE, Estrada-Gutierrez G, Irles C, Giono-Cerezo S, Bloch RJ, Nataro JP. Effects of the plasmid-encoded toxin of enteroaggregative Escherichia coli on focal adhesion complexes. FEMS Immunol Med Microbiol. 2011;61:301–14.PubMedCrossRef Cappello RE, Estrada-Gutierrez G, Irles C, Giono-Cerezo S, Bloch RJ, Nataro JP. Effects of the plasmid-encoded toxin of enteroaggregative Escherichia coli on focal adhesion complexes. FEMS Immunol Med Microbiol. 2011;61:301–14.PubMedCrossRef
62.
go back to reference • Boisen N, Scheutz F, Rasko DA, Redman JC, Persson S, Simon J, et al. Genomic characterization of enteroaggregative Escherichia coli from children in Mali. J Infect Dis. 2012;205:431–44. In this paper, an mPCR and comparative genome hybridization analysis of a collection of enteroaggregative E. coli (EAEC) strains was performed, and a subset of EAEC strains that are pathogenic was defined, including the identification of a marker for the most virulent isolates. PubMedCrossRef • Boisen N, Scheutz F, Rasko DA, Redman JC, Persson S, Simon J, et al. Genomic characterization of enteroaggregative Escherichia coli from children in Mali. J Infect Dis. 2012;205:431–44. In this paper, an mPCR and comparative genome hybridization analysis of a collection of enteroaggregative E. coli (EAEC) strains was performed, and a subset of EAEC strains that are pathogenic was defined, including the identification of a marker for the most virulent isolates. PubMedCrossRef
63.
go back to reference • Edwards LA, Bajaj-Elliott M, Klein NJ, Murch SH, Phillips AD. Bacterial-epithelial contact is a key determinant of host innate immune responses to enteropathogenic and enteroaggregative Escherichia coli. PLoS One. 2011;6:e27030. This paper characterizes which bacterial motifs contribute to the innate epithelial response to enteropathogenic E. coli and enteroaggregative E. coli, using a range of E. coli isogenic mutant strains. PubMedCrossRef • Edwards LA, Bajaj-Elliott M, Klein NJ, Murch SH, Phillips AD. Bacterial-epithelial contact is a key determinant of host innate immune responses to enteropathogenic and enteroaggregative Escherichia coli. PLoS One. 2011;6:e27030. This paper characterizes which bacterial motifs contribute to the innate epithelial response to enteropathogenic E. coli and enteroaggregative E. coli, using a range of E. coli isogenic mutant strains. PubMedCrossRef
64.
go back to reference • Boll EJ, Struve C, Sander A, Demma Z, Krogfelt KA, McCormick BA. Enteroaggregative Escherichia coli promotes transepithelial migration of neutrophils through a conserved 12-lipoxygenase pathway. Cell Microbiol. 2012;14:120–32. This paper found that polymorphonuclear neutrophils (PMN) transepithelial migration promoted enhanced attachment of enteroaggregative E. coli (EAEC) to T84 cells and suggested that EAEC-induced PMN infiltration may favor colonization and, thus, pathogenesis of EAEC. PubMedCrossRef • Boll EJ, Struve C, Sander A, Demma Z, Krogfelt KA, McCormick BA. Enteroaggregative Escherichia coli promotes transepithelial migration of neutrophils through a conserved 12-lipoxygenase pathway. Cell Microbiol. 2012;14:120–32. This paper found that polymorphonuclear neutrophils (PMN) transepithelial migration promoted enhanced attachment of enteroaggregative E. coli (EAEC) to T84 cells and suggested that EAEC-induced PMN infiltration may favor colonization and, thus, pathogenesis of EAEC. PubMedCrossRef
65.
go back to reference Aslani MM, Alikhani MY, Zavari A, Yousefi R, Zamani AR. Characterization of enteroaggregative Escherichia coli (EAEC) clinical isolates and their antibiotic resistance pattern. Int J Infect Dis. 2011;15:e136–9.PubMedCrossRef Aslani MM, Alikhani MY, Zavari A, Yousefi R, Zamani AR. Characterization of enteroaggregative Escherichia coli (EAEC) clinical isolates and their antibiotic resistance pattern. Int J Infect Dis. 2011;15:e136–9.PubMedCrossRef
66.
go back to reference Mortensen NP, Fowlkes JD, Maggart M, Doktycz MJ, Nataro JP, Drusano G, et al. Effects of sub-minimum inhibitory concentrations of ciprofloxacin on enteroaggregative Escherichia coli and the role of the surface protein dispersin. Int J Antimicrob Agents. 2011;38:27–34.PubMedCrossRef Mortensen NP, Fowlkes JD, Maggart M, Doktycz MJ, Nataro JP, Drusano G, et al. Effects of sub-minimum inhibitory concentrations of ciprofloxacin on enteroaggregative Escherichia coli and the role of the surface protein dispersin. Int J Antimicrob Agents. 2011;38:27–34.PubMedCrossRef
67.
go back to reference Ouyang-Latimer J, Jafri S, VanTassel A, Jiang ZD, Gurleen K, Rodriguez S, et al. In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008. Antimicrob Agents Chemother. 2011;55:874–8.PubMedCrossRef Ouyang-Latimer J, Jafri S, VanTassel A, Jiang ZD, Gurleen K, Rodriguez S, et al. In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008. Antimicrob Agents Chemother. 2011;55:874–8.PubMedCrossRef
68.
go back to reference Darfeuille-Michaud A. Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn’s disease. Int J Med Microbiol. 2002;292:185–93.PubMedCrossRef Darfeuille-Michaud A. Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn’s disease. Int J Med Microbiol. 2002;292:185–93.PubMedCrossRef
69.
go back to reference Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology. 2004;127:412–21.PubMedCrossRef Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology. 2004;127:412–21.PubMedCrossRef
70.
go back to reference Eaves-Pyles T, Allen CA, Taormina J, Swidsinski A, Tutt CB, Jezek GE, et al. Escherichia coli isolated from a Crohn’s disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells. Int J Med Microbiol. 2008;298:397–409.PubMedCrossRef Eaves-Pyles T, Allen CA, Taormina J, Swidsinski A, Tutt CB, Jezek GE, et al. Escherichia coli isolated from a Crohn’s disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells. Int J Med Microbiol. 2008;298:397–409.PubMedCrossRef
71.
go back to reference Nash JH, Villegas A, Kropinski AM, Aguilar-Valenzuela R, Konczy P, Mascarenhas M, et al. Genome sequence of adherent-invasive Escherichia coli and comparative genomic analysis with other E. coli pathotypes. BMC Genomics. 2010;11:667.PubMedCrossRef Nash JH, Villegas A, Kropinski AM, Aguilar-Valenzuela R, Konczy P, Mascarenhas M, et al. Genome sequence of adherent-invasive Escherichia coli and comparative genomic analysis with other E. coli pathotypes. BMC Genomics. 2010;11:667.PubMedCrossRef
Metadata
Title
Clinical Implications of Enteroadherent Escherichia coli
Authors
Margarita M. P. Arenas-Hernández
Ygnacio Martínez-Laguna
Alfredo G. Torres
Publication date
01-10-2012
Publisher
Current Science Inc.
Published in
Current Gastroenterology Reports / Issue 5/2012
Print ISSN: 1522-8037
Electronic ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-012-0277-1

Other articles of this Issue 5/2012

Current Gastroenterology Reports 5/2012 Go to the issue

Small Intestine (B Cash, Section Editor)

Advanced Colorectal Polyp Detection Techniques

Large Intestine (B Cash, Section Editor)

The Colonic Microbiota and Colonic Disease

Small Intestine (J Sellin, Section Editor)

Novel Treatments for NEC: Keeping IBD in Mind